Profound Medical Corp Stock Today
| PRN Stock | CAD 8.77 0.02 0.23% |
PerformanceSoft
| Odds Of DistressLow
|
Profound Medical is selling at 8.77 as of the 8th of February 2026; that is 0.23% increase since the beginning of the trading day. The stock's open price was 8.75. Profound Medical has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 10th of November 2025 and ending today, the 8th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. The company has 36.29 M outstanding shares of which 150.43 K shares are at this time shorted by private and institutional investors with about 7.97 days to cover all short positions. More on Profound Medical Corp
Moving together with Profound Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Profound Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Profound Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Profound Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | ||||
Profound Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Profound Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsProfound Medical utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Profound Medical's leverage profile, showing how much of Profound Medical's resources are funded through borrowing.
| |||||
Profound Medical Corp (PRN) is traded on Toronto Exchange in Canada and employs 142 people. Profound Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 318.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Profound Medical's market, we take the total number of its shares issued and multiply it by Profound Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Profound Medical Corp operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 36.29 M outstanding shares of which 150.43 K shares are at this time shorted by private and institutional investors with about 7.97 days to cover all short positions.
Profound Medical Corp has accumulated about 27.05 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Check Profound Medical Probability Of Bankruptcy
Ownership AllocationProfound Medical owns a total of 36.29 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Profound Ownership Details
Profound Medical Historical Income Statement
Profound Stock Against Markets
Profound Stock Analysis Notes
About 35.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.81. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. PROFOUND MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 64 people. To find out more about Profound Medical Corp contact Arun MBA at 647 476 1350 or learn more at https://www.profoundmedical.com.Profound Medical Quarterly Total Revenue |
|
Profound Medical Corp Investment Alerts
| Profound Medical had very high historical volatility over the last 90 days | |
| The company has C$5.12 Million in debt which may indicate that it relies heavily on debt financing | |
| The company reported the revenue of 10.68 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 10.36 M. | |
| Profound Medical Corp has accumulated about 27.05 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Latest headline from news.google.com: Daily Stock Insights - Stock Traders Daily |
Profound Largest EPS Surprises
Earnings surprises can significantly impact Profound Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.41 | -0.36 | 0.05 | 12 | ||
2019-08-14 | 2019-06-30 | -0.45 | -0.5 | -0.05 | 11 | ||
2019-03-07 | 2018-12-31 | -0.45 | -0.5 | -0.05 | 11 |
Profound Medical Thematic Classifications
In addition to having Profound Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Profound Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 318.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Profound Medical's market, we take the total number of its shares issued and multiply it by Profound Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Profound Profitablity
Profound Medical's profitability indicators refer to fundamental financial ratios that showcase Profound Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Profound Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Profound Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Profound Medical's profitability requires more research than a typical breakdown of Profound Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.75) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.69) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.69. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.36) | (0.38) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.36) | (0.37) | |
| Return On Equity | (0.41) | (0.44) |
Management Efficiency
Profound Medical Corp has return on total asset (ROA) of (0.6244) % which means that it has lost $0.6244 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.2449) %, meaning that it generated substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 8th of February 2026, Return On Tangible Assets is likely to drop to -0.38. In addition to that, Return On Capital Employed is likely to drop to -0.49. As of the 8th of February 2026, Fixed Asset Turnover is likely to grow to 12.29, while Total Assets are likely to drop about 49.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.81 | 3.43 | |
| Tangible Book Value Per Share | 2.79 | 3.15 | |
| Enterprise Value Over EBITDA | (7.79) | (8.18) | |
| Price Book Value Ratio | 3.98 | 3.89 | |
| Enterprise Value Multiple | (7.79) | (8.18) | |
| Price Fair Value | 3.98 | 3.89 | |
| Enterprise Value | 250.4 M | 266.5 M |
Leadership effectiveness at Profound Medical Corp is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 8th of February, Profound Medical holds the Coefficient Of Variation of 2626.69, risk adjusted performance of 0.0386, and Semi Deviation of 3.38. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Profound Medical, as well as the relationship between them.Profound Medical Corp Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Profound Medical Corp Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Profound Medical price patterns.
Profound Medical Outstanding Bonds
Profound Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Profound Medical Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Profound bonds can be classified according to their maturity, which is the date when Profound Medical Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Profound Medical Predictive Daily Indicators
Profound Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Profound Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Profound Medical Forecast Models
Profound Medical's time-series forecasting models are one of many Profound Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Profound Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Profound Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Profound Medical Corporate Management
Elected by the shareholders, the Profound Medical's board of directors comprises two types of representatives: Profound Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Profound. The board's role is to monitor Profound Medical's management team and ensure that shareholders' interests are well served. Profound Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Profound Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.